Donghai Xiong

Title: The Innovative Contributions of Donghai Xiong

Introduction

Donghai Xiong is a notable inventor based in Franklin, Wisconsin. He has made significant contributions to the field of medical research, particularly in understanding hyperprogressive disease (HPD) in patients undergoing anti-PD-1 immunotherapy. His work is crucial for advancing cancer treatment and improving patient outcomes.

Latest Patents

Donghai Xiong holds a patent titled "Gene expression signature of hyperprogressive disease (HPD) in patients after anti-PD-1 immunotherapy." This patent describes a method for determining a patient's HPD status by examining tumor samples for the expression levels of specific HPD-diagnostic biomarkers. The process involves determining whether the signature of these biomarkers aligns with that of a HPD positive signature. He has 1 patent to his name.

Career Highlights

Donghai Xiong is affiliated with the Medical College of Wisconsin, Inc., where he conducts his research. His work focuses on the intersection of immunotherapy and cancer biology, contributing to a deeper understanding of how certain patients respond to treatment.

Collaborations

He collaborates with esteemed colleagues, including Ming You and Yian Wang, to further his research initiatives and enhance the impact of his findings in the medical community.

Conclusion

Donghai Xiong's innovative work in the field of cancer research exemplifies the importance of understanding patient responses to immunotherapy. His contributions are paving the way for more effective treatment strategies in the fight against cancer.